Drug Acquisition definition

Drug Acquisition means any acquisition (including any license or any acquisition of any license) solely or primarily of all or any portion of the rights in respect of one or more drugs or pharmaceutical products, whether in development or on the market (including related intellectual property), but not of Equity Interests in any Person or any operating business unit.
Sample 1Sample 2Sample 3
Drug Acquisition means any acquisition (including any license or any acquisition of any license) solely or primarily of all or any portion of the rights in respect of one or more drugs or pharmaceutical products, whether in development or on market, and related property or assets, but not of Equity Interests in any Person or any operating business unit.
Sample 1Sample 2Sample 3
Drug Acquisition means any acquisition (including any license or any acquisition of any license) solely or primarily of all
Sample 1

Examples of Drug Acquisition in a sentence

  • If the Department implements the use of Maximum Allowable Ingredient Costs (MAICs) for drugs, which have three (3) or more generically equivalent options available, reimbursement for the affected drug(s) may change if the MAIC is “lesser of” the two other benchmarks defined in state law, i.e., National Average Drug Acquisition Cost and Federal Upper Limit.

  • The National Average Drug Acquisition Cost (NADAC) pricing will be used for AAC when available.

  • The National Average Drug Acquisition Cost (NADAC) is based on a review of invoices and published by Centers for Medicare and Medicaid Services (CMS) and will be used in the determination of AAC.

  • Facilities purchasing drugs at Nominal Price (outside of 340B or FSS) shall be reimbursed by their actual acquisition cost.B. The National Average Drug Acquisition Cost (NADAC) is a pricing benchmark published by CMS that calculates ingredient average acquisition costs experienced by retail community providers across the country.

  • The Division will better align with a cost-based reimbursement methodology by: (1) Applying the rate set by the National Average Drug Acquisition Cost (NADAC) when there is no Oregon Average Actual Acquisition Cost (AAAC) and (2) Removing consideration of the Federal Upper Limit (FUL).

  • PBMs shall follow the standards announced by the Commissioner in AID Bulletins 11- 2021, 13-2021 and 5-2022 for maximum allowable cost and National Average Drug Acquisition Cost (“NADAC”) reimbursement processing.

  • Ms. Kirby provided an update on the upcoming changes to the pharmacy reimbursement methodology, including the use of National Average Drug Acquisition Cost (NADAC).

  • When ASP data are not available for the oral drugs used in OTPs, use the TRICARE rate to set the payment for the drug component of the methadone bundle, and National Average Drug Acquisition Cost (NADAC) data to set the payment for the drug component of the oral buprenorphine bundle.

  • The Contractor must maintain up-to-date prices for Wholesale Acquisition Cost (WAC), Maximum Allowable Cost (MAC), National Average Drug Acquisition Cost (NADAC), Federal Upper Limit (FUL), 340B ceiling prices, and any other applicable pricing options required by the Commonwealth.

  • The Center for Medicare and Medicaid Services (CMS) requires all states to conduct a COD analysis for their pharmacy providers and reimburse them this amount for each Medicaid fee-for-service (FFS) claim on top of the cost to acquire the drug as measured by National Average Drug Acquisition Cost (NADAC) or a state’s own Actual Acquisition Cost (AAC).


More Definitions of Drug Acquisition

Drug Acquisition means any acquisition (including any license or any acquisition of any license) solely or primarily of all or any portion of the rights in respect of one or more drugs or pharmaceutical products, whether in development or on market (including related intellectual property), but not of Equity Interests in any Person or any operating business unit unless such rights constitute all or substantially all of such Person’s or operating business’ assets. “Early Opt-in Effective Date” means, with respect to any Early Opt-in Election, the sixth (6th) Business Day after the date notice of such Early Opt-in Election is provided to the Lenders, so long as the Administrative Agent has not received, by 5:00 p.m. (New York City time) on the fifth (5th) Business Day after the date notice of such Early Opt-in Election is provided to the Lenders, written notice of objection to such Early Opt-in Election from Lenders comprising the Required Lenders. “Early Opt-in Election” means the occurrence of: (a) a determination by the Administrative Agent, or a notification by the Borrower to the Administrative Agent that the Borrower has made a determination, that U.S. dollar-denominated syndicated credit facilities currently being executed, or that include language similar to that contained in Section 3.03(c), are being executed or amended (as applicable) to incorporate or adopt a new benchmark interest rate to replace LIBOR, and (b) the joint election by the Administrative Agent and the Borrower to replace LIBOR with a Benchmark Replacement and the provision by the Administrative Agent of written notice of such election to the Lenders. “EEA Financial Institution” means (a) any credit institution or investment firm established in any EEA Member Country which is subject to the supervision of an EEA Resolution Authority, (b) any entity established in an EEA Member Country which is a parent of an institution described in clause (a) of this definition, or (c) any financial institution established in an EEA Member Country which is a Subsidiary of an institution described in clauses (a) or (b) of this definition and is subject to consolidated supervision with its parent. “EEA Member Country” means any of the member states of the European Union, Iceland, Liechtenstein, and Norway. “EEA Resolution Authority” means any public administrative authority or any Person entrusted with public administrative authority of any EEA Member Country (including any delegee) having responsibility for the reso...
Sample 1

Related to Drug Acquisition

  • Material Acquisition means any (a) acquisition of property or series of related acquisitions of property that constitutes assets comprising all or substantially all of an operating unit, division or line of business or (b) acquisition of or other investment in the Capital Stock of any Subsidiary or any person which becomes a Subsidiary or is merged or consolidated with the Borrower or any of its Subsidiaries, in each case, which involves the payment of consideration by the Borrower and its Subsidiaries in excess of $100,000,000 (or the equivalent in other currencies).

  • Land acquisition means the taking of or alienation of land, buildings or other assets thereon for purposes of the Project.

  • Closing Date Acquisition shall have the meaning assigned to such term in the recitals hereto.

  • Limited Condition Acquisition means any acquisition, including by way of merger, by the Borrower or one or more of its Restricted Subsidiaries permitted pursuant to this Agreement whose consummation is not conditioned upon the availability of, or on obtaining, third party financing.